Katina Makris

House Bill 1933 requires physicians to provide written disclosure to people who are tested for Lyme disease. The disclosure statement informs those who have taken a Lyme disease test that current laboratory testing can produce false negatives, especially in the early stage of the disease. If symptoms persist, retesting could be considered. Early detection of Lyme disease is critical to successfully treating the disease and its co-infections.